In consultation: Guidance and quality standards

Skip to filters Skip to results

Showing 1 to 2 of 2

Sort by

Guidance programme: Highly specialised technologies guidanceRemove Guidance programme: Highly specialised technologies guidance filter
Guidance programme: Technology appraisal guidanceRemove Guidance programme: Technology appraisal guidance filter
Guidance programme: Cancer service guidelinesRemove Guidance programme: Cancer service guidelines filter
Guidance programme: Diagnostics guidanceRemove Guidance programme: Diagnostics guidance filter
Guidance programme: Public health guidelinesRemove Guidance programme: Public health guidelines filter

Guidance and quality standards in consultation
Title	Consultation	Type	Consultation end date
Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 (MA review of HST12) [ID6145]	Draft guidance	Highly specialised technology	6 June 2025
Adagrasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer [ID6339]	Draft guidance	Technology appraisal guidance	2 June 2025

Results per page

10
25
50
All